LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Expanding Orthopedics Expands Patent Line
Spine

Expanding Orthopedics Expands Patent Line

October 27, 2014 1 min read Premium comments

Advertisement

Expanding Orthopedics Expands Patent Line
FLXfit / Courtesy: Expanding Orthopedics
Secondary

Mark Levy, M.D. an orthopedic surgeon and founder of Expanding Orthopedics, said in the October 22, 2014 news release, “My vision, since I founded the company, was to develop a unique family of expandable devices covering spine and trauma applications, creating a new standard of care. This 13th granted U.S. patent covers innovative technologies in the area of expandable interbody cages and VCF [vertebral compression fractures] solutions. This confirms our ability to develop together, with our advising surgeons, state-of-the-art devices which, ultimately, provide patients with improved clinical outcome.”

Ofer Bokobza, EOI’s CEO, commented, “This new patent demonstrates our continuous commitment to innovation and reinforces our position as a leading innovator in the area of expandable devices. While our Sales & Marketing team is currently focused on bringing the FDA cleared FLXfit 3D expandable cage to the U.S. market, our engineering team continues to work on the next generation of expandable devices to meet surgeons’ evolving needs. We are dedicated to a continuous pursuit of raising the bar in providing a new standard of care in spine surgery.”

Bokobza told OTW, “This patent covers several claims and devices among them are expandable cage and expandable VCF device. The company is now focused on the commercializing stage of the FLXfit, our unique 3D expandable cage, in the U.S. We have signed our first distribution agreement in the U.S. and are now in the process of signing additional distributors in the U.S.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy